Scientists found that combining oxytocin with an Alk5 inhibitor revitalized extremely old male mice, boosting their lifespan and strength. Female mice showed only short-term improvements, highlighting ...
A cancer-targeting antibody that helps the body's immune cells spot and destroy hard-to-treat tumors such as triple-negative ...
Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsWilliam Meury - CEO, ...
TiumBio lists Tosposertib as WHO international nonproprietary name and advances phase 2 trials in Korea TiumBio advances ...
Discover the essential role of TGF-Beta 1 in cellular regulation, its signaling pathway, and how TGF-β1 antibodies are used ...
As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted Accounting Principles (GAAP) are increasingly recognized as meaningful signals of ...
Visugromab combined with nivolumab showed a median duration of response exceeding two years in refractory NSCLC, UC, and HCC patients. GDF-15 is a therapeutic target and immune escape mechanism, ...
Cannabidiol may help prevent scarring on the eye’s surface, according to a new lab study published in Scientific Reports by ...
Cellular death within the infarcted core occurs rapidly due to energy depletion, resulting in the release of DAMPs such as ...
Inflammatory biomarkers in ischemic stroke: mechanisms, clinical applications, and future directions
Ischemic stroke is a complex cerebrovascular disorder characterized by highly unpredictable outcomes influenced by ...
Review explores how drug repurposing in oncology can reshape the tumor microenvironment, strengthen immune checkpoint ...
KaliVir Immunotherapeutics, Inc., a clinical-stage biotechnology company developing cutting-edge, multi-mechanistic oncolytic immunotherapies, today announced a clinical trial collaboration and supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback